Literature DB >> 23009

Immunopathology.

S Sell.   

Abstract

Mesh:

Substances:

Year:  1978        PMID: 23009      PMCID: PMC2018222     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  19 in total

1.  Introduction: myasthenia gravis in perspective.

Authors:  D Grob
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

Review 2.  Australia antigen and the biology of hepatitis B.

Authors:  B S Blumberg
Journal:  Science       Date:  1977-07-01       Impact factor: 47.728

Review 3.  Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens.

Authors:  K E Hellström; I Hellström
Journal:  Adv Immunol       Date:  1974       Impact factor: 3.543

4.  Immuno-pathology of leprosy: the century in review. Pathology, pathogenesis, and the development of classification.

Authors:  O K Skinsnes
Journal:  Int J Lepr Other Mycobact Dis       Date:  1973 Jul-Sep

Review 5.  Immunologic tissue injury mediated by neutrophilic leukocytes.

Authors:  C G Cochrane
Journal:  Adv Immunol       Date:  1968       Impact factor: 3.543

Review 6.  Auto-immune hemolytic anemias.

Authors:  J V Dacie; S M Worlledge
Journal:  Prog Hematol       Date:  1969

7.  The complement system.

Authors:  M M Mayer
Journal:  Sci Am       Date:  1973-11       Impact factor: 2.142

Review 8.  The alternative pathway of complement activation.

Authors:  O Götze; H J Müller-Eberhard
Journal:  Adv Immunol       Date:  1976       Impact factor: 3.543

9.  The embryo as a transplant.

Authors:  A E Beer; R E Billingham
Journal:  Sci Am       Date:  1974-04       Impact factor: 2.142

Review 10.  Immunological facilitation, a broadening of the concept of the enhancement phenomenon.

Authors:  G A Voisin
Journal:  Prog Allergy       Date:  1971
View more
  1 in total

Review 1.  The vascular endothelium-pathobiologic significance.

Authors:  G Thorgeirsson; A L Robertson
Journal:  Am J Pathol       Date:  1978-12       Impact factor: 4.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.